WikiMD Resources 360

W8MD Diet | COVID-19 portal | Vitamin D | Vaccine | Keto

WikiMD is the world's largest medical encyclopedia with
14,007 pages, 4,159,079 edits & 43,392,504 views.

Free unbiased diet, health and wellness info!


From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search


A recombinant human IgG1 monoclonal antibody (MoAb) directed against the tumor associated antigen (TAA) epithelial cell adhesion molecule (EpCAM) with potential antitumor activity. Adecatumumab binds to EpCAM, which may result in antibody-dependent cellular cytotoxicity (ADCC) directed against EpCAM-expressing tumor cells. EpCAM (CD326), a cell surface protein upregulated on many tumor cell types, promotes the proliferation, migration and invasiveness of tumor cells; for some cancers, overexpression has been correlated with decreased survival.

Learn more about Adecatumumab

Latest research - Adecatumumab

Clinical trials

External links

Medicine icon
Medicine icon

This WikiMD article Adecatumumab is a stub. If you are familiar with the topic Adecatumumab, you can help us. Paid editors welcome!

Monoclonal antibodies for tumors

Human ("-tumu-") * Adecatumumab§
Mouse ("-tumo-")

ltumomab pentetate



Chimeric ("-tuxi-") * Amatuximab§
Humanized ("-tuzu-") * Abituzumab§
Rat/mouse hybrid


* Catumaxomab
Chimeric + humanized


* Depatuxizumab mafodotin
  • #WHO-EM
  • ‡Withdrawn from market
  • Clinical trials: 
    • †Phase III
    • §Never to phase III

Adecatumumab is part of WikiMD's free ^articles!

^Adecatumumab (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available